457 related articles for article (PubMed ID: 29046446)
1. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
2. Insulated Foamy Viral Vectors.
Browning DL; Collins CP; Hocum JD; Leap DJ; Rae DT; Trobridge GD
Hum Gene Ther; 2016 Mar; 27(3):255-66. PubMed ID: 26715244
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes.
Zhou S; Fatima S; Ma Z; Wang YD; Lu T; Janke LJ; Du Y; Sorrentino BP
Mol Ther; 2016 Jun; 24(6):1090-1099. PubMed ID: 26957223
[TBL] [Abstract][Full Text] [Related]
4. Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.
Suerth JD; Maetzig T; Brugman MH; Heinz N; Appelt JU; Kaufmann KB; Schmidt M; Grez M; Modlich U; Baum C; Schambach A
Mol Ther; 2012 May; 20(5):1022-32. PubMed ID: 22334016
[TBL] [Abstract][Full Text] [Related]
5. Viral Vectors: The Road to Reducing Genotoxicity.
David RM; Doherty AT
Toxicol Sci; 2017 Feb; 155(2):315-325. PubMed ID: 27803388
[TBL] [Abstract][Full Text] [Related]
6. Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus.
Beard BC; Keyser KA; Trobridge GD; Peterson LJ; Miller DG; Jacobs M; Kaul R; Kiem HP
Hum Gene Ther; 2007 May; 18(5):423-34. PubMed ID: 17518616
[TBL] [Abstract][Full Text] [Related]
7. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors.
Ikawa Y; Uchiyama T; Jagadeesh GJ; Candotti F
Gene Ther; 2016 Nov; 23(11):815-818. PubMed ID: 27487944
[TBL] [Abstract][Full Text] [Related]
8. Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region.
Arumugam PI; Higashimoto T; Urbinati F; Modlich U; Nestheide S; Xia P; Fox C; Corsinotti A; Baum C; Malik P
Mol Ther; 2009 Nov; 17(11):1929-37. PubMed ID: 19707188
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the in vivo safety of insulated foamy viral vectors.
Browning DL; Everson EM; Leap DJ; Hocum JD; Wang H; Stamatoyannopoulos G; Trobridge GD
Gene Ther; 2017 Mar; 24(3):187-198. PubMed ID: 28024082
[TBL] [Abstract][Full Text] [Related]
10. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
Rethwilm A
Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
[TBL] [Abstract][Full Text] [Related]
11. 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors.
Manic G; Maurin-Marlin A; Galluzzi L; Subra F; Mouscadet JF; Bury-Moné S
Hum Gene Ther Methods; 2012 Apr; 23(2):84-97. PubMed ID: 22456436
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.
Everson EM; Hocum JD; Trobridge GD
J Gene Med; 2018 Jul; 20(7-8):e3028. PubMed ID: 29935087
[TBL] [Abstract][Full Text] [Related]
13. Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element.
Hanawa H; Yamamoto M; Zhao H; Shimada T; Persons DA
Mol Ther; 2009 Apr; 17(4):667-74. PubMed ID: 19223867
[TBL] [Abstract][Full Text] [Related]
14. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.
Cornils K; Bartholomae CC; Thielecke L; Lange C; Arens A; Glauche I; Mock U; Riecken K; Gerdes S; von Kalle C; Schmidt M; Roeder I; Fehse B
Exp Hematol; 2013 Jan; 41(1):28-38.e3. PubMed ID: 22989760
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation.
Scholz SJ; Fronza R; Bartholomä CC; Cesana D; Montini E; von Kalle C; Gil-Farina I; Schmidt M
Hum Gene Ther; 2017 Oct; 28(10):875-885. PubMed ID: 28825370
[TBL] [Abstract][Full Text] [Related]
16. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.
Montini E; Cesana D; Schmidt M; Sanvito F; Bartholomae CC; Ranzani M; Benedicenti F; Sergi LS; Ambrosi A; Ponzoni M; Doglioni C; Di Serio C; von Kalle C; Naldini L
J Clin Invest; 2009 Apr; 119(4):964-75. PubMed ID: 19307726
[TBL] [Abstract][Full Text] [Related]
17. Suppression of clonal dominance in cultured human lymphoid cells by addition of the cHS4 insulator to a lentiviral vector.
Evans-Galea MV; Wielgosz MM; Hanawa H; Srivastava DK; Nienhuis AW
Mol Ther; 2007 Apr; 15(4):801-9. PubMed ID: 17299406
[TBL] [Abstract][Full Text] [Related]
18. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator.
Ramezani A; Hawley TS; Hawley RG
Blood; 2003 Jun; 101(12):4717-24. PubMed ID: 12586614
[TBL] [Abstract][Full Text] [Related]
19. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
[TBL] [Abstract][Full Text] [Related]
20. An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation.
Ryu BY; Evans-Galea MV; Gray JT; Bodine DM; Persons DA; Nienhuis AW
Blood; 2008 Feb; 111(4):1866-75. PubMed ID: 17991809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]